These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17556202)

  • 21. Molecular basis of arrhythmias.
    Shah M; Akar FG; Tomaselli GF
    Circulation; 2005 Oct; 112(16):2517-29. PubMed ID: 16230503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac sodium channel and inherited arrhythmia syndromes.
    Bezzina CR; Rook MB; Wilde AA
    Cardiovasc Res; 2001 Feb; 49(2):257-71. PubMed ID: 11164836
    [No Abstract]   [Full Text] [Related]  

  • 23. Inherited sodium channelopathies: novel therapeutic and proarrhythmic molecular mechanisms.
    Balser JR
    Trends Cardiovasc Med; 2001 Aug; 11(6):229-37. PubMed ID: 11673053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic aspects of arrhythmias.
    Roberts R; Brugada R
    Am J Med Genet; 2000; 97(4):310-8. PubMed ID: 11376443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse models of SCN5A-related cardiac arrhythmias.
    Charpentier F; Bourgé A; Mérot J
    Prog Biophys Mol Biol; 2008; 98(2-3):230-7. PubMed ID: 19041666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do defects in ion channel glycosylation set the stage for lethal cardiac arrhythmias?
    Fozzard HA; Kyle JW
    Sci STKE; 2002 Apr; 2002(130):pe19. PubMed ID: 11983936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular underpinning of "good luck".
    Priori SG; Napolitano C
    Circulation; 2006 Aug; 114(5):360-2. PubMed ID: 16880338
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
    Smits JP; Blom MT; Wilde AA; Tan HL
    Expert Opin Pharmacother; 2008 Mar; 9(4):537-49. PubMed ID: 18312156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome.
    Nuyens D; Stengl M; Dugarmaa S; Rossenbacker T; Compernolle V; Rudy Y; Smits JF; Flameng W; Clancy CE; Moons L; Vos MA; Dewerchin M; Benndorf K; Collen D; Carmeliet E; Carmeliet P
    Nat Med; 2001 Sep; 7(9):1021-7. PubMed ID: 11533705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation.
    Horne AJ; Eldstrom J; Sanatani S; Fedida D
    Heart Rhythm; 2011 May; 8(5):770-7. PubMed ID: 21193062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long QT syndrome: from channels to cardiac arrhythmias.
    Moss AJ; Kass RS
    J Clin Invest; 2005 Aug; 115(8):2018-24. PubMed ID: 16075042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling the genetics and mechanisms of cardiac arrhythmia.
    Noble D
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5755-6. PubMed ID: 11983875
    [No Abstract]   [Full Text] [Related]  

  • 35. Can common genetic variations combine to produce the long QT syndrome phenotype?
    Kaufman ES
    Heart Rhythm; 2005 Jul; 2(7):748-9. PubMed ID: 15992733
    [No Abstract]   [Full Text] [Related]  

  • 36. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms?
    Nerbonne JM
    Trends Cardiovasc Med; 2004 Apr; 14(3):83-93. PubMed ID: 15121155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
    Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
    J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
    ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
    Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.